Toggle Sidebar
Tracking
The Digest
Dashboard
Changes
Readouts
Trials
Companies
Comparisons
Automation
Nightly sweep
Settings
Tracker
↳
Sign in
Sign in
Explore the registry
Track Atogepant 30 mg's trials
Efficacy, Safety, and Tolerability of Atogepant for the Prevention of Chronic Migraine
Atogepant 30 mg
Completed
Completed
Phase 3
Open NCT03855137 on ClinicalTrials.gov ↗
Population
Loading…
Intervention
Loading…
Comparator
Loading…
Outcomes
Loading…
Overview
Endpoints
Eligibility
Full record
